Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation (ACHDAF)
Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation:A Single-center,Retrospective,Observational Study
Sponsor: Henan Institute of Cardiovascular Epidemiology
A observational or N/A phase clinical study on Atrial Fibrillation and Coronary Heart Disease, this trial is ongoing. The trial is conducted by Henan Institute of Cardiovascular Epidemiology and has accumulated 11 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Jan 2020 — Jan 2021 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Apr 2019 — Jan 2020 [monthly]
Recruiting
-
Sep 2018 — Apr 2019 [monthly]
Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Apr 2017 — Apr 2018 [monthly]
Recruiting NA
-
Feb 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Henan Institute of Cardiovascular Epidemiology
For direct contact, visit the study record on ClinicalTrials.gov .